In this review, we introduce the various biosynthetic and bioenergetic roles of glutamine based on the compartmentalization of glutamine metabolism to explain why cells exhibit metabolic reliance on glutamine
In most adult somatic cells, telomerase activity is very low or absent, allowing telomere shortening to proceed unchecked
I think this is a great point, and I read a similar discussion on that explained this idea in even more depth
Over time, pharmacological engineering enabled: Short-acting injectables (e.g., exenatide) Long-acting once-weekly injectables (liraglutide, semaglutide) Multi-target incretin therapies (tirzepatide) Oral peptide formulations and now oral small molecules The most recent breakthrough is the development of orally available GLP-1 receptor agonists, including: Orforglipron (Lilly) Elecoglipron (AstraZeneca) These compounds eliminate the need for injection and could dramatically expand accessibility and adherence in obesity and diabetes populations
The third is shifting glucose metabolism in people also taking diabetes medications
Vu offers GLP-1 weight loss injections to help patients achieve their health and aesthetic goals